Key result
27-hydroxycholesterol increased URAT1/SLC22A12 gene promoter activity and expression in mouse kidneys and human kidney organoids via estrogen response elements.
Why the study?
Elevated uric acid levels are linked to diseases including gout, atherosclerosis, and renal dysfunction, but the transcriptional regulation of uric acid reabsorption transporters remained incompletely understood.
The endogenous selective estrogen receptor modulator 27-hydroxycholesterol upregulates URAT1/SLC22A12 expression, providing a mechanistic link between cholesterol metabolism and serum uric acid regulation.
Links cholesterol metabolism to urate handling in preclinical models; leaves open human relevance and clinical implications.
Elevated levels of uric acid, a metabolite of purine in humans, is related to various diseases, such as gout, atherosclerosis and renal dysfunction. The excretion and reabsorption of uric acid to/from urine is tightly regulated by uric acid transporters. The amino acid sequences of uric acid reabsorption transporters, URAT1/ SLC22A12 , OAT4/ SLC22A11 , and OAT10/ SLC22A13 , share closer phylogenic relationship, whereas the gene promoter sequences are distant phylogenic relationship. Through the single-cell RNA-sequencing analysis of an adult human kidney, we found that only a small number of cells express these transporters, despite their role in the regulation of serum uric acid levels. Transcriptional motif analysis on these transporter genes, revealed that the URAT1/ SLC22A12 gene promoter displayed the most conserved estrogen response elements (EREs) among the three transporters. The endogenous selective estrogen receptor modulator (SERM) 27-hydroxycholesterol (27HC) had positive effects on the transcriptional activity of URAT1/ SLC22A12 . We also found that 27HC increased the protein and gene expression of URAT1/ SLC22A12 in mouse kidneys and human kidney organoids, respectively. These results strongly suggest the role of 27HC for URAT1/ SLC22A12 expression in renal proximal tubules and upregulation of serum uric acid levels and also show the relationship between cholesterol metabolism and serum uric acid regulation. Significance Statement The elevated levels of serum uric acid cause various diseases, and the excretion/reabsorption of uric acid to/from urine is tightly regulated by the uric acid transporters. We found that despite the role in serum uric acid regulation, only a small number of cells express URAT1/ SLC22A12 . We also found that URAT1/ SLC22A12 gene promoter region has effective estrogen response elements, and endogenous selective estrogen receptor (ER) modulator 27-hydroxycholesterol (27HC) increased URAT1/ SLC22A12 expression in the mice kidneys and human kidney organoids. These suggest that 27HC increases URAT1/ SLC22A12 expression and upregulate serum uric acid levels. Since 27HC connects cholesterol metabolism, our study indicates the important link between cholesterol metabolism and serum uric acid regulation, and also provides a novel therapeutic approach to hyperuricemia.
No takes yet. Share an insight, caveat, or question.
Matsubayashi et al. (2019) studied Hyperuricemia. 27-hydroxycholesterol (27HC) vs. Control was evaluated on URAT1/SLC22A12 gene promoter activity. 27-hydroxycholesterol increased URAT1/SLC22A12 gene promoter activity and expression in mouse kidneys and human kidney organoids via estrogen response elements.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: